Setronomet 8mg 4 OroDispersible Tablet

• SETRONOMET Oral Dispersible Tablet is indicated for the prevention of nausea and vomiting. • Active ingredient: Ondansetron 8mg • Indication: o For the prevention of nausea and vomiting associated with:  Highly emetogenic cancer chemotherapy.  Radiotherapy o For the prevention of postoperative nausea and/or vomiting. • Dosage and administration: o It should be described by physician. o It is not indicated for the treatment of children less than 4 years old.